FER | Fer (fps/fes related) tyrosine kinase | Enzymes Plasma proteins
| | | | | Mixed |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
GEMIN5 | Gem (nuclear organelle) associated protein 5 | | | | | | Expressed in all |
GFM2 | G elongation factor, mitochondrial 2 | Mitochondrial proteins
| | | | | Expressed in all |
GFPT2 | Glutamine-fructose-6-phosphate transaminase 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GFRA3 | GDNF family receptor alpha 3 | Predicted membrane proteins
| | | | | Mixed |
GLRX | Glutaredoxin (thioltransferase) | Plasma proteins
| | | | | Expressed in all |
GOLPH3 | Golgi phosphoprotein 3 (coat-protein) | | | | | | Expressed in all |
GPBP1 | GC-rich promoter binding protein 1 | | | | | | Expressed in all |
GPX8 | Glutathione peroxidase 8 (putative) | Enzymes
| | | | | Mixed |
GRPEL2 | GrpE-like 2, mitochondrial (E. coli) | Mitochondrial proteins
| | | | | Expressed in all |
H2AFY | H2A histone family, member Y | Plasma proteins
| | | | | Expressed in all |
HARS | Histidyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
HAVCR2 | Hepatitis A virus cellular receptor 2 | Predicted membrane proteins
| | | | | Mixed |
HDAC3 | Histone deacetylase 3 | Enzymes FDA approved drug targets
| | | | | Expressed in all |
HINT1 | Histidine triad nucleotide binding protein 1 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | Enzymes Plasma proteins
| | | | | Expressed in all |
HMMR | Hyaluronan-mediated motility receptor (RHAMM) | CD markers FDA approved drug targets
| | | | | Mixed |
HNRNPA0 | Heterogeneous nuclear ribonucleoprotein A0 | Plasma proteins
| | | | | Expressed in all |
HNRNPAB | Heterogeneous nuclear ribonucleoprotein A/B | Plasma proteins
| | | | | Expressed in all |
HSD17B4 | Hydroxysteroid (17-beta) dehydrogenase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
HSPA4 | Heat shock 70kDa protein 4 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
HSPA9 | Heat shock 70kDa protein 9 (mortalin) | Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
IK | IK cytokine, down-regulator of HLA II | | | | | | Expressed in all |
IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRF1 | Interferon regulatory factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
IRX1 | Iroquois homeobox 1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ISL1 | ISL LIM homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
JADE2 | Jade family PHD finger 2 | | | | | | Expressed in all |
JAKMIP2 | Janus kinase and microtubule interacting protein 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
JMY | Junction mediating and regulatory protein, p53 cofactor | Cytoskeleton related proteins
| | | | | Expressed in all |
KDM3B | Lysine (K)-specific demethylase 3B | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
KIF20A | Kinesin family member 20A | | | | | | Mixed |
KIF4B | Kinesin family member 4B | Plasma proteins
| | | | | Tissue enriched |
LARP1 | La ribonucleoprotein domain family, member 1 | Plasma proteins
| | | | | Expressed in all |
LARS | Leucyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LIFR | Leukemia inhibitory factor receptor alpha | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
LMNB1 | Lamin B1 | Disease related genes Plasma proteins
| | | | | Mixed |
LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LSM11 | LSM11, U7 small nuclear RNA associated | | | | | | Mixed |
MAML1 | Mastermind-like 1 (Drosophila) | | | | | | Expressed in all |
MAN2A1 | Mannosidase, alpha, class 2A, member 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MAP1B | Microtubule-associated protein 1B | Plasma proteins
| | | | | Tissue enhanced |
MATR3 | Matrin 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
MBLAC2 | Metallo-beta-lactamase domain containing 2 | | | | | | Mixed |
MCC | Mutated in colorectal cancers | | | | | | Tissue enhanced |
MCCC2 | Methylcrotonoyl-CoA carboxylase 2 (beta) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |